Cell painting on Araceli Endeavor HCI Platform produces comparable phenotypic profiles
14 Jul 2025
The speed at which researchers can deliver high content results is currently limited by the speed at which they can acquire plates. In this presentation, Dr. Fernanda Garcia Fóssa, from the Compound Management and Screening Center (COMAS) at the Max Planck Institute of Molecular Physiology, shares how they reduced image acquisition from 3.5 hours per plate to just 7 minutes per plate using the Araceli Endeavor® platform. Dr. Martin Theiss also outlines the full Endeavor® portfolio from Araceli Biosciences, including the new Endeavor® Pro and Endeavor® Ultra.
Hear insights directly from the Araceli experts in this video interview.
This video was filmed at SLAS Europe 2025.
About the company

Araceli Biosciences
Araceli Biosciences is on a mission to create cutting-edge technologies that empower researchers to accelerate therapeutic discovery. Speed is essential for furthering our understanding of biology and helps in finding better drug candidates with more confidence upstream in the drug discovery pipeline by acquiring high quality data that produce actionable answers. Our goal is to be the leader in predictive AI-based image acquisition and analysis, enabling more informed decisions to increase therapeutic success. We envision a future where patients have earlier access to the most effective treatments.

